Recently, accumulating evidence based on intensive lifestyle intervention studies has proved the attainability of T2D remission, such as the Diabetes Remission Clinical Trial (DiRECT) study, which achieved 46% remission among short‐duration T2D, apart from bariatric surgery and intensive insulin therapy.4, 5, 6. This evidence concerns the gene INS and type 2 diabetes mellitus.